2325 V (Benztropine 0.5 mg)
Pill imprint 2325 V has been identified as Benztropine mesylate 0.5 mg.
Benztropine is used in the treatment of extrapyramidal reaction; hyperhidrosis; parkinson's disease and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy. Benztropine 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 2325 V
- Strength:
- 0.5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Qualitest Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00603-2433
- Inactive Ingredients:
- croscarmellose sodium
calcium phosphate dibasic anhydrous
lactose monohydrate
magnesium stearate
microcrystalline cellulose
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0404 | UDL Laboratories Inc |
| 68084-0381 | Amerisource Health Services |
Note: Inactive ingredients may vary.
More about benztropine
Consumer resources
- Benztropine
- Benztropine tablets
- Benztropine (Advanced Reading)
- Benztropine Injection (Advanced Reading)
- Other brands: Cogentin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
